How Much Will I Get From the $15.2M Valsartan, Losartan and Irbesartan class action settlement?

Based on the $15.2 Million total fund and estimated claimant participation, the per-person payout for the $15.2M Valsartan, Losartan and Irbesartan class action settlement is estimated at $40 – $200. However, actual payouts depend on the total number of valid claims filed and final court approval.

The Aurobindo settlement benefits consumers who paid for irbesartan medications manufactured with Aurobindo irbesartan active pharmaceutical ingredients since Jan. 1, 2016. The Hetero settlement benefits consumers who paid for valsartan medications manufactured using Hetero Process III API sold between May 1, 2018 and July 31, 2018. The Vivimed settlement benefits consumers who paid for Vivimed losartan finished drug formulations sold under specific impacted National Drug Codes.

Yes — this settlement requires documentation. You'll need proof of purchase, account statements, or other evidence showing your involvement with Valsartan, Losartan and Irbesartan. Providing documentation typically results in a higher payout.

The deadline to file a claim for the $15.2M Valsartan, Losartan and Irbesartan class action settlement is June 2, 2026. That is 42 days from today. Make sure to file before this date to receive your share of the settlement.

The $15.2M Valsartan, Losartan and Irbesartan class action settlement has a total fund of $15.2 Million. This fund is divided among all valid claimants. With an estimated ~127K people, the per-person payout is estimated at $40 – $200. If fewer people file claims, individual payouts may be higher. If participation exceeds estimates, payouts may be lower.

After the filing deadline passes, the settlement administrator reviews all claims, resolves disputes, and receives final court approval. This process typically takes 3–18 months. Once approved, payments are distributed via check, PayPal, Venmo, or gift cards depending on the settlement terms.